ReviewRSC advances2025
Polymeric nanocarriers in drug delivery, bioimaging, and biosensing: advances and perspectives on nanomicelles, nanogels, and dendrimers.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A highly sensitive and reusable electrochemical immunosensor based on biofunctionalized graphene paper for the detection of the lung cancer-associated biomarker GM2AP.Mikrochimica acta · 2026Article
- Article
- Engineering Strategies of Colloidal Drug Delivery Systems, a Rising Star in Ocular Neovascular Diseases.Molecules (Basel, Switzerland) · 2026Review
- Interpreting the Theranostic Applications of Alumina and Silica Substrates in Cancer.Molecules (Basel, Switzerland) · 2026Review
- Targeted delivery of berberineNanoscale advances · 2026Article
- Novel High-Atomic-Number Element and Nanoparticle-Based CT Contrast Agents: Advanced Design Strategies and Clinical Translational Barriers.International journal of nanomedicine · 2026Review
- From nanoscale to clinic: The growing impact of nanotechnology in translational drug delivery.ADMET & DMPK · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymeric nanocarriers such as nanomicelles, nanogels, and dendrimers are critical nanomedicine tools, providing novel drug delivery, bioimaging, and biosensing solutions. The design, synthesis, and potential of polymeric nanocarriers to solve long-term biomedical issues are addressed in this review. Nanomicelles, which are self-assembled from amphiphilic copolymers, increase drug solubility such as paclitaxel and allow stimuli-responsive site-specific release controlled by pH or light. Nanogels comprising water-holding polymer networks deliver and protect a broad variety of agents, ranging from anticancer drugs to insulin, across barriers, such as the blood-brain barrier (BBB). Tree-branched dendrimers enhance drug delivery and contrast imaging through precise molecular conjugation. For bioimaging, these carriers increase the resolution of magnetic resonance imaging (MRI), computed tomography (CT), and near-infrared (NIR) fluorescence imaging, while for biosensing, they enable sensitive detection of glucose and other analytes. Despite their potential, scalability, and clinical translation, challenges exist. This review charts their groundbreaking impact through case studies and paving the way for personalized medicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.